# MultiStem® Administration for Stroke Treatment and Enhanced Recovery Study

> **NCT03545607** · PHASE3 · UNKNOWN · sponsor: **Healios K.K.** · enrollment: 300 (estimated)

## Conditions studied

- Ischemic Stroke

## Interventions

- **BIOLOGICAL:** MultiStem
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT03545607
- **Lead sponsor:** Healios K.K.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-07-28
- **Primary completion:** 2022-09
- **Final completion:** 2023-06
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2022-02-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03545607

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03545607, "MultiStem® Administration for Stroke Treatment and Enhanced Recovery Study". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT03545607. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*